This is AWESOME news and confirms what I and a few others have been saying on this forum for months now.... that ARG-007 is a very promising candidate for therapeutic use in alzheimer's patients. Great to see the company exploring this absolutely massive market for which there is no decent treatment.
This is AWESOME news and confirms what I and a few others have...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
81.0¢ |
Change
-0.020(2.41%) |
Mkt cap ! $102.9M | |||
| Open | High | Low | Value | Volume |
| 85.0¢ | 85.5¢ | 81.0¢ | $80.99K | 98.04K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 20011 | 81.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 85.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| AGN (ASX) Chart |